Ergomed PLC | Income Statement

Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
15,147.00
21,155.00
30,178.00
39,233.00
47,624.00
54,112
Cost of Goods Sold (COGS) incl. D&A
10,209.00
15,902.00
22,521.00
28,266.00
34,629.00
37,391
Gross Income
4,938.00
5,253.00
7,657.00
10,967.00
12,995.00
16,721
SG&A Expense
3,171.00
3,944.00
5,357.00
10,468.00
12,462.00
17,887
EBIT
1,767.00
1,309.00
2,300.00
-
533.00
1,382
Unusual Expense
-
584.00
309.00
1,123.00
4,610.00
9,177
Non Operating Income/Expense
9.00
54.00
81.00
401.00
408.00
229
Interest Expense
2.00
2.00
1.00
2.00
35.00
3
Pretax Income
1,778.00
777.00
2,072.00
223.00
4,447.00
10,768
Income Tax
232.00
199.00
520.00
153.00
57.00
1,788
Consolidated Net Income
1,546.00
578.00
1,552.00
70.00
4,504.00
8,980
Net Income
1,546.00
578.00
1,552.00
70.00
4,504.00
8,980
Net Income After Extraordinaries
1,546.00
578.00
1,552.00
70.00
4,504.00
8,980
Net Income Available to Common
1,546.00
578.00
1,552.00
70.00
4,504.00
8,980
EPS (Basic)
0.08
0.02
0.05
0.00
0.11
0.20
Basic Shares Outstanding
20,000.00
24,075.30
28,750.00
35,573.70
41,086.20
44,852.50
EPS (Diluted)
0.07
0.02
0.05
0.00
0.11
0.20
Diluted Shares Outstanding
20,941.20
25,068.90
29,765.20
37,034.10
41,086.20
44,852.50
EBITDA
1,830.00
1,828.00
3,013.00
1,526.00
2,159.00
1,151
Non-Operating Interest Income
4.00
-
1.00
2.00
3.00
23

About Ergomed

View Profile
Address
The Surrey Research Park
Guildford Surrey GU2 7YD
United Kingdom
Employees -
Website http://ergomedplc.com/
Updated 07/08/2019
Ergomed Plc is a clinical development company. The company is engaged in the provision of services to the pharmaceutical industry and the development of orphan drugs. It focuses on the development of oncology, neurology and immunology drugs.